- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06680154
Induction and Stabilization of Gamma Oscillations With 40 Hz External Brain Stimulation
March 15, 2026 updated by: Mohammad Ali Salehinejad, The National Brain Mapping Laboratory (NBML)
Gamma Oscillations and Working Memory Following Combined 40Hz tACS and iTBS
The goal of the present studies is to develop and validate novel stimulation protocols for the entrainment of gamma oscillations, which are associated with many cognitive functions and critically involved in cognitive impairment such as Alzheimer's disease.
In this proposal, combination of repetitive transcranial magnetic stimulation (rTMS) and transcranial alternating current stimulation (tACS), which has been shown effective for the induction, and stabilisation of alpha and theta frequencies in our forgoing studies, will be adopted to the gamma frequency range and applied on prefrontal regions as well as model-based cortical areas to enhance and stabilize gamma oscillations, thereby facilitating cognition
Study Overview
Status
Completed
Detailed Description
Neuropsychiatric disorders are a leading cause of global disability-adjusted life years, and treatment solutions are lacking.
Recent findings suggest that non-invasive brain stimulation may be a valuable option in conditions such as epilepsy or Alzheimer's disease (AD).
Still, a better understanding of mechanisms and patient-specific factors is needed.
Personalized hybrid brain models uniting the physics of electromagnetism with physiology - NeuroTwins (NeTs) - are poised to play a fundamental role in understanding and optimizing the effects of stimulation at the individual level.
The purpose of this project is to deliver solutions through model-driven, individualized therapy.
A computational framework - weaved and validated across scales and levels of detail - will be proposed to represent the mechanisms of interaction of electric fields with brain networks and assimilate neuroimaging data.
This will allow us to characterize the dynamical landscape of the individual brain and define strategies to restore healthy dynamics.
The work package, which will take place at IfADo, is part of the consortium collaborating with labs across Europe and USA, aiming to validate and optimize the realistic hybrid brain models developed by NeTs.
The targeted subject groups of the IfADo project will be healthy young and old participants.
Non-invasive brain stimulation including repetitive transcranial magnetic stimulation and transcranial alternating current stimulation will be applied with electroencephalography, and magnetic resonance spectroscopy as outcome measures.
The results are to be translated into a technology pipeline for the design of new personalized neuromodulation protocols which will further be tested in a cohort of AD patients by another clinical consortium member, delivering model-driven breakthroughs in basic and clinical neuroscience, with patients ultimately benefiting from safe, individualized therapy solutions.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Rhine-Westphalia
-
Dortmund, North Rhine-Westphalia, Germany, 44139
- Leibniz-Institut für Arbeitsforschung
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- normal or corrected to normal eye vision
- right-handed
- non-smokers
- being 18-60 years old
- providing written informed consent
Exclusion Criteria:
- history of neurological or psychiatric disorders including seizures or epilepsy,
- Taking CNS medication
- having metal implants
- current pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Transcranial alternating current stimulation
During tACS, an alternating electrical current with a 1 milliamp peak-to-peak amplitude will be delivered, featuring a 15-second ramp-up at the start and a 15-second ramp-down at the end.
The stimulation duration is 20 minutes and four channels are used for delivering sinusoidal alternating currents to the head.
The alternating current was delivered to the prefrontal cortex bilaterally with the electrodes at F3 and F4 and the return electrodes were placed at the ipsilateral mastoids at TP9 and TP10 (international 10-20 EEG electrode placement system).
|
Transcranial alternating current was delivered utilizing a Starstim 8-channel constant current, battery-powered electric stimulator (Neuroelectrics, Barcelona, Spain).
Circular carbon rubber electrodes (2cm radius, 12,57 cm2) were used throughout the stimulation.
Before placing the electrodes on the head, the subject's hair was moved to the side
|
|
Active Comparator: intermittent theta burst stimulation
The intermittent theta burst stimulation (iTBS) is regarded as safe for high-frequency neuromodulation.
The pulse bursts are applied for two seconds in 5Hz intervals followed by an eight-second break before the next bursts are applied.
This pattern is repeated for 190 seconds resulting in 600 pulses per protocol.
80% of the individual subjects' active motor threshold (AMT) are used for stimulation intensity and will be applied four times within a 20-minute time frame starting at 0 minutes, 5 minutes, 10 minutes, and 15 minutes from the beginning of the intervention resulting in 2400 delivered pulses for the whole intervention
|
the intermittent theta burst stimulation (iTBS) which is regarded as safe for high-frequency neuromodulation.
Compared to classical rTMS, where pulses are applied repeatedly at a fixed frequency, iTBS consists of bursts of pulse triplets.
In the classical protocol, the bursts are applied for two seconds in 5Hz intervals followed by an eight-second break, before the next bursts are applied.
This pattern is repeated for 190 seconds resulting in 600 pulses per protocol.
|
|
Active Comparator: combited iTBS- tACS peak
To combine tACS and the iTBS protocol, a customized circuit is developed in-house to phase-lock the TMS pulses to the waveform generated by tACS.
TMS pulses were delivered using two figure-of-eight shaped coils (double 70 mm, PMD coil type; Mag and More GmbH, Munich, Germany).
For the stimulation, the center of the TMS coils are placed over the two prefrontal tACS electrodes (F3 and F4 electrode positions) with an orientation of 45 degrees to the midline and the handles pointing backward.
Using the customized circuit, TMS pulses will be delivered at the peak of the tACS wave.
|
Transcranial alternating current was delivered utilizing a Starstim 8-channel constant current, battery-powered electric stimulator (Neuroelectrics, Barcelona, Spain).
Circular carbon rubber electrodes (2cm radius, 12,57 cm2) were used throughout the stimulation.
Before placing the electrodes on the head, the subject's hair was moved to the side
the intermittent theta burst stimulation (iTBS) which is regarded as safe for high-frequency neuromodulation.
Compared to classical rTMS, where pulses are applied repeatedly at a fixed frequency, iTBS consists of bursts of pulse triplets.
In the classical protocol, the bursts are applied for two seconds in 5Hz intervals followed by an eight-second break, before the next bursts are applied.
This pattern is repeated for 190 seconds resulting in 600 pulses per protocol.
|
|
Active Comparator: Combined iTBS-tACS trough
To combine tACS and the iTBS protocol, a customized circuit is developed in-house to phase-lock the TMS pulses to the waveform generated by tACS.
TMS pulses were delivered using two figure-of-eight shaped coils (double 70 mm, PMD coil type; Mag and More GmbH, Munich, Germany).
For the stimulation, the center of the TMS coils are placed over the two prefrontal tACS electrodes (F3 and F4 electrode positions) with an orientation of 45 degrees to the midline and the handles pointing backward.
Using the customized circuit, TMS pulses will be delivered at the trough of the tACS wave.
|
Transcranial alternating current was delivered utilizing a Starstim 8-channel constant current, battery-powered electric stimulator (Neuroelectrics, Barcelona, Spain).
Circular carbon rubber electrodes (2cm radius, 12,57 cm2) were used throughout the stimulation.
Before placing the electrodes on the head, the subject's hair was moved to the side
the intermittent theta burst stimulation (iTBS) which is regarded as safe for high-frequency neuromodulation.
Compared to classical rTMS, where pulses are applied repeatedly at a fixed frequency, iTBS consists of bursts of pulse triplets.
In the classical protocol, the bursts are applied for two seconds in 5Hz intervals followed by an eight-second break, before the next bursts are applied.
This pattern is repeated for 190 seconds resulting in 600 pulses per protocol.
|
|
Sham Comparator: sham
80% of the individual subjects' active motor threshold (AMT) four times within a 20-minute time frame starting at 0 minutes, 5 minutes, 10 minutes, and 15 minutes from the beginning of the intervention resulting in 2400 delivered pulses for the whole intervention
|
In the case of sham TMS, two different sham coils (double 70mm pCool-SHAM coil, Mag&More GmbH, Munich, Germany) will produce audible clicks at the decibel intensity corresponding to an active coil without the induction of an electromagnetic pulse.
Sham tACS will be applied by only ramping the current for 15 seconds up and 15 seconds down at the beginning and end of the stimulation respectively.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Working Memory behavioral performance
Time Frame: During procedure (20 minutes)
|
Participants view a continuous sequence of alphabet letters, presented as stimuli in Arial font, size 120pt, on a tube screen positioned at 60cm eye distance.
The stimuli are shown with a time interval of two seconds between them.
The task consisted of six blocks with 70 stimuli, including 12 possible hit trials.
Participants were instructed to press the left key on a response box if the presented stimulus matched either the one presented one trial prior (1-Back) or three trials prior (3-Back).
In all other cases, participants press the right key.
The left button is pressed with the index finger, while the right button is pressed with the middle finger of the right hand, with buttons aligned horizontally.
The response condition varied by block, with three blocks for 3-Back and three for 1-Back, and the order was counterbalanced across participants and sessions.
|
During procedure (20 minutes)
|
|
electroencephalogram (EEG) oscillatory power
Time Frame: up to 2 hours after the intervention
|
Change in the EEG power in alpha, delta, theta and beta bands
|
up to 2 hours after the intervention
|
|
electroencephalogram (EEG) functional connectivity
Time Frame: up to 2 hours after the intervention
|
Change in EEG functional connectivity, specifically global efficiency, coherence, and phase-locking value.
|
up to 2 hours after the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 13, 2021
Primary Completion (Actual)
November 30, 2023
Study Completion (Actual)
November 30, 2023
Study Registration Dates
First Submitted
November 5, 2024
First Submitted That Met QC Criteria
November 7, 2024
First Posted (Actual)
November 8, 2024
Study Record Updates
Last Update Posted (Actual)
March 18, 2026
Last Update Submitted That Met QC Criteria
March 15, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Mental Disorders
- Neurocognitive Disorders
- Dementia
- Tauopathies
- Neurodegenerative Diseases
- Alzheimer Disease
- Therapeutics
- Behavioral Disciplines and Activities
- Electric Stimulation Therapy
- Convulsive Therapy
- Psychiatric Somatic Therapies
- Electroshock
- Psychological Techniques
- Transcranial Direct Current Stimulation
Other Study ID Numbers
- IfADo_196
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer Disease
-
ProgenaBiomeWithdrawnAlzheimer Disease | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3 | Alzheimer Disease 4 | Alzheimer Disease 7 | Alzheimer Disease 17 | Alzheimer Disease 5 | Alzheimer Disease 6 | Alzheimer Disease 8 | Alzheimer Disease 10 | Alzheimer... and other conditionsUnited States
-
Cognito Therapeutics, Inc.Active, not recruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditionsUnited States
-
Stanford UniversityNot yet recruitingMCI With Increased Risk for Alzheimer Disease | Alzheimer s DiseaseUnited States
-
University of California, Los AngelesRecruitingAlzheimer Disease | Dementia Alzheimer Type | Alzheimer&Amp;#39;s Disease (AD) | Alzheimer&Amp;Amp;#39;s Disease | Mild Alzheimer&Amp;Amp;#39;s Disease | Moderate Alzheimer&Amp;Amp;#39;s Disease | Alzheimer&Amp;#39;s DementiaUnited States
-
AphiosNot yet recruitingDementia | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3
-
Heinrich-Heine University, DuesseldorfNot yet recruitingEarly Onset Alzheimer Disease | Alzheimer Disease (AD)Germany
-
University Hospital, GrenobleRecruiting
-
Fujian Medical University Union HospitalRecruitingAlzheimer s DiseaseChina
-
AkesoNot yet recruitingAlzheimer' s DiseaseChina
-
Johns Hopkins UniversityNational Institutes of Health (NIH)Not yet recruiting
Clinical Trials on Transcranial alternating current stimulation
-
QVITI S.A.CompletedStroke | AphasiaPoland
-
Anhui Medical UniversityRecruitingNon-suicidal Self-injury | Depression DisordersChina
-
I.R.C.C.S. Fondazione Santa LuciaActive, not recruitingAlzheimer DiseaseItaly
-
Universidad Metropolitana de Ciencias de la EducacionCompletedRehabilitation | Chronic StrokeChile
-
Anhui Provincial HospitalNot yet recruitingDementia | Mild Cognitive Impairment | Alzheimer's Disease
-
First Affiliated Hospital of Zhejiang UniversityRecruitingConsciousness DisordersChina
-
A.J.C. SlooterRadboud University Medical Center; HagaZiekenhuisRecruiting
-
Anhui Medical UniversityRecruitingEarly Alzheimer's Disease | Electroencephalography | Transcranial Alternating Current StimulationChina
-
Anhui Medical UniversityRecruitingMagnetic Resonance Imaging | Anxiety Disorder | Transcranial Alternating Current StimulationChina
-
University of ManitobaRecruitingDementia; Degenerative, Dementia MixedCanada